Clinical Trial Update: Pembrolizumab Plus Bevacizumab for Treatment of Brain Metastases in Metastatic Melanoma or Non-small Cell Lung Cancer (NSCLC) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pembrolizumab in combination with bevacizumab for treatment of brain metastases in metastatic melanoma or non-small cell lung cancer; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Melanoma
• Non-small Cell Lung Cancer

Drugs mentioned

• Avastin (bevacizumab)
• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Yale University | Conditions: Melanoma, Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2025-08-07